Pharmacology of Ondansetron
Introduction/Overview Ondansetron represents a cornerstone agent in the therapeutic management of nausea and vomiting. Its development marked a significant advancement in supportive care, particularly within oncology, by effectively addressing a dose-limiting and profoundly distressing side effect of cytotoxic chemotherapy and radiotherapy. As a selective antagonist of the serotonin 5-hydroxytryptamine type 3 (5-HT3) receptor, ondansetron exerts … Read more